As of Oct 21
| -0.0858 / -8.98%|
The 3 analysts offering 12-month price forecasts for Biocept Inc have a median target of 3.60, with a high estimate of 7.50 and a low estimate of 2.40. The median estimate represents a +313.79% increase from the last price of 0.87.
The current consensus among 3 polled investment analysts is to Buy stock in Biocept Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.